Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Merck & Co., Inc. (NYSE:MRK). “I have tremendous, tremendous faith in what Robert Davis [CEO of Merck] is doing,” he added.
When asked about Teladoc Health, Inc (NYSE:TDOC), he said, “What's going on there, right now we've got this Cathie Wood, she sells the stock almost every day. She bought it much higher, it's really painful to watch.”
Fortinet, Inc. (NASDAQ:FTNT) reported a “very good” quarter, he said. “I remain committed to Nikesh Arora [CEO of Palo Alto Networks] and Palo Alto Networks (NASDAQ:PANW), which I think is doing the best of all of them.”
Enova International, Inc. (NYSE:ENVA) is a “little dicey,” Cramer said, “A little dicey because it's untraditional lending. I am just a traditionalist. I say go with the stock that collapsed over the last week, go with Wells Fargo & Co (NYSE:WFC).”
“This is enterprise software, and, you know, there is more money being lost in enterprise software in 2024 than in any other sector, so I can't play, I'm sorry,” Cramer said when asked about Bentley Systems, Incorporated (NASDAQ:BSY).
GE HealthCare Technologies Inc. (NASDAQ:GEHC) reported a “decent” quarter and has been hurt by China, he said. “I bought the worst of the three, and I'm not proud of myself.”
Price Action:
Read Next:
Photo: Shutterstock